51. Genome-scale hypomethylation in the cord blood DNAs associated with early onset preeclampsia
- Author
-
Lana X. Garmire, Travers Ching, Janos Molnar, Dena Towner, James Ha, Min-Ae Song, Marla J. Berry, and Maarit Tiirikainen
- Subjects
Bioinformatics ,Physiology ,Preeclampsia ,03 medical and health sciences ,0302 clinical medicine ,Genetics ,medicine ,Epigenetics ,Molecular Biology ,Genetics (clinical) ,030304 developmental biology ,0303 health sciences ,Fetus ,DNA methylation ,030219 obstetrics & reproductive medicine ,business.industry ,Research ,Early onset preeclampsia ,Case-control study ,Cord blood ,medicine.disease ,Human genetics ,3. Good health ,business ,Developmental Biology - Abstract
Background Preeclampsia is one of the leading causes of fetal and maternal morbidity and mortality worldwide. Preterm babies of mothers with early onset preeclampsia (EOPE) are at higher risks for various diseases later on in life, including cardiovascular diseases. We hypothesized that genome-wide epigenetic alterations occur in cord blood DNAs in association with EOPE and conducted a case control study to compare the genome-scale methylome differences in cord blood DNAs between 12 EOPE-associated and 8 normal births. Results Bioinformatics analysis of methylation data from the Infinium HumanMethylation450 BeadChip shows a genome-scale hypomethylation pattern in EOPE, with 51,486 hypomethylated CpG sites and 12,563 hypermethylated sites (adjusted P
- Published
- 2015